Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA

NCT06856135 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Crohn's Disease
Ulcerative Colitis

Interventions

DRUG: Vedolizumab IV

Sponsor

Takeda